1-4 of 4
Deborah Anderson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ARRY-520 Combined With Pomalidomide Displays Enhanced Anti-Tumor Activity In Preclinical Models Of Multiple Myeloma

Michael J Humphries, PhD, Deborah Anderson, Lance Williams, Rob Rieger, Brian Tunquist, PhD, Duncan Walker, PhD
Journal: Blood
Blood (2013) 122 (21): 3167.
https://doi.org/10.1182/blood.V122.21.3167.3167
Published: 2013
Journal Articles

Enzastaurin in Patients with Non-Hodgkin Lymphomas: A Multicenter, Open-Label, Screening Study.

Cecily J. Forsyth, David Gomez, Paul Eliadis, Erick Crespo-Solis, Juliana Pereira, Stephanie Roberson, Deborah Anderson, Oday Hamid, Neil V Smith
Journal: Blood
Blood (2009) 114 (22): 3719.
https://doi.org/10.1182/blood.V114.22.3719.3719
Published: 2009
Journal Articles

Activity of ARRY-614, an Inhibitor of p38 Map Kinase and Angiogenic Targets, in Hematologic Malignancies.

Shannon L. Winski, PhD, Stefan D. Gross, PhD, Suzy A. Brown, BS, Deborah Anderson, BS, Augusta Garrison, MS, Mareli Rodriguez, MS, Patrice Lee, PhD, Mark Munson, PhD, James Winkler, PhD
Journal: Blood
Blood (2007) 110 (11): 4798.
https://doi.org/10.1182/blood.V110.11.4798.4798
Published: 2007
Journal Articles

ARRY-797, a Potent and Selective Inhibitor of p38 Map Kinase, Inhibits LPS-Induced IL-6 and In Vivo Growth of RPMI-8226 Human Multiple Myeloma Cells.

Dale Wright, PhD, Shannon L. Winski, Ph.D., Deborah Anderson, Patrice Lee, Ph.D., Mark Munson, Ph.D., James Winkler, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 3478.
https://doi.org/10.1182/blood.V108.11.3478.3478
Published: 2006